Repression of cancer cell senescence by PKCι
Paget, J A, Restall, I J, Daneshmand, M, Mersereau, J A, Simard, M A, Parolin, D A E, Lavictoire, S J, Amin, M S, Islam, S, Lorimer, I A J
Published in Oncogene (02.08.2012)
Published in Oncogene (02.08.2012)
Get full text
Journal Article
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
Goss, G, Hirte, H, Miller, Jr, W H, Lorimer, I A J, Stewart, D, Batist, G, Parolin, D A E, Hanna, P, Stafford, S, Friedmann, J, Walsh, W, Mathews, S, Douglas, L, Seymour, L K
Published in Investigational new drugs (01.01.2005)
Published in Investigational new drugs (01.01.2005)
Get full text
Journal Article
Repression of cancer cell senescence by PKC[iota]
Paget, J A, Restall, I J, Daneshmand, M, Mersereau, J A, Simard, M A, Parolin, D A E, Lavictoire, S J, Amin, M S, Islam, S, Lorimer, I A J
Published in Oncogene (02.08.2012)
Published in Oncogene (02.08.2012)
Get full text
Journal Article